Patent · US Active

Crystal form of pyrimidine sulfonamide compound and preparation method therefor

US12297192B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

Wuxi Biocity Biopharmaceuticals Co., Ltd. · CN

Inventors

Junmiao LI · Shanghai, CN
Maoyi LEI · Shanghai, CN
Yunfu Luo · Shanghai, CN

Key dates

Filing date	May 22, 2020
Grant date	May 13, 2025
Priority date	—
Expiry date	Apr 18, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed are a Crystal Form (I) of a pyrimidine sulfonamide compound and a preparation method therefor. The present disclosure relates to an application thereof in the preparation of a medicament for treating diseases related to ETA receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.